No Data
Dongyang Sunshine Pharmaceutical (06887) issued a profit alert, expecting approximately RMB 270 million in net profit attributable to shareholders for the fiscal year 2025, turning losses into profits year-on-year.
Dongyangguang Pharmaceutical (06887) announced that for the fiscal year ended December 31, 2025, the group expects to achieve a net profit attributable to shareholders of approximately RMB 270 million, representing an increase of approximately 228.57% compared to a net loss attributable to shareholders of approximately RMB 210 million in the same period last year.
SUNSHINE PHARMA: POSITIVE PROFIT ALERT
Selected Hong Kong Stock Announcements | HaiZhi Technology Partners with ZhiPu AI for Strategic Collaboration; Green Tea Group Reports Over 30% Year-on-Year Increase in Annual Profit
① What are the highlights of the strategic cooperation between Haizhi Technology and Zhipu? ② Green Tea Group's annual profit increased by more than 30% year-on-year. What is the scale?
Guolian Minsheng Securities: Small Nucleic Acids Reshape Weight Loss Logic; INHBE and ALK7 Targets Preliminarily Validated
Small nucleic acids and GLP-1 drugs exhibit synergistic effects, with major weight loss companies already investing in small nucleic acid drugs. GLP-1 controls intake, while small nucleic acids regulate metabolism, making them a potential 'golden combination' in the field of weight management.
Stock Movement | Dongyang Pharmaceutical (06887) rose over 4% in early trading after the company announced a significant strategic cooperation agreement with XtalPi Holdings.
Dongyangguang Pharmaceutical (06887) rose over 4% in early trading. As of the time of writing, it was up 4.06%, trading at HKD 46.68 with a turnover of HKD 13.8169 million.
Hong Kong Stock Announcements | Dongpeng Beverages begins its IPO subscription today. Joyson Electronic expects an increase of approximately 40.56% in annual net profit attributable to shareholders.
Zijin Gold International proposes to acquire 100% of Allied Gold Corporation for approximately CAD 5.5 billion.